• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome

    2020-10-30 08:13:58NobuyukiYoshiyasuMasaakiSato
    World Journal of Transplantation 2020年5期

    Nobuyuki Yoshiyasu, Masaaki Sato

    Abstract

    Key words: Lung transplantation; Chronic lung allograft dysfunction; Bronchiolitis obliterans syndrome; Restrictive allograft syndrome; Interaction of immune cells;Anatomical changes in transplanted lungs

    INTRODUCTION

    Lung transplantation is an established surgical treatment for end-stage respiratory failure. Since the first successful case of clinical lung transplantation in 1983[1], the short-term survival within 1 year is over 80% because of better surgical techniques and perioperative management[2]. However, the overall survival at 5 years is still approximately 50%-70% without much improvement[3], and is worse than that of other solid-organ transplantations[4]. Chronic lung allograft dysfunction (CLAD) has been the most common cause of poor survival for the past 35 years. Half of recipients receiving lung transplantation develop CLAD within 5 years[5,6], which aggravates their respiratory condition and worsens prognosis. The pathological condition of CLAD is thought not to be associated with chronic rejection alone, but rather as a multifactorial syndrome[7-12]. The lung is a unique organ that is consistently exposed to the external environment and is easily affected by external stimuli including infection[8-11], air pollution, and aspiration[12,13]. Until recently, CLAD was recognized as bronchiolitis obliterans syndrome (BОS) when it was first introduced in 1993[14]. The main histologic findings of BОS include obliterative bronchiolitis (ОB) accompanying chronic inflammation and fibrosis in the respiratory tract[15,16]. In 2010, the concept of restrictive allograft syndrome (RAS), which accompanies restrictive ventilatory impairment and a poor prognosis, was proposed as a new entity of CLAD[17].Interestingly, in pathological specimens of RAS patients, inflammation and fibrotic lesions were observed in the respiratory tract as well as the visceral pleura and peripheral lung tissues. RAS accounts for one-third to one-fourth of all cases of CLAD. A lower survival rate after RAS onset was shown in multiple lung transplant centers (survival period: 1 year for RASvs2.5 years for BОS)[18,19]. In response, the pulmonary council of International Society for Heart and Lung Transplantation(ISHLT) formulated the international diagnostic criteria for RAS in 2019[20].Accordingly, the new definitions and diagnostic criteria for CLAD and BОS were also published in another consensus report[21]. The framework of CLAD has greatly changed, and further study is now needed to elucidate the mechanisms involved for each phenotype. This review summarizes the new definition of CLAD and provides some mechanistic insights obtained from clinicopathological observations and animal experiments.

    NEW DEFINITION OF CLAD

    CLAD is defined as a substantial and persistent decline in the measured forced expiratory volume in 1 second (FEV1) with ≥ 20% from the baseline value. The baseline value was set as the mean value of the two best FEV1values following lung transplantation, which were measured at least 3 wk apart[21].

    Three steps to diagnose CLAD according to its progress

    Possible CLAD: FEV1declined by ≥ 20% from the reference value but the duration of functional decline is still within 3 wk, irrespective of any forced vital capacity (FVC)changes.

    Probable CLAD: FEV1is still < 80% of the reference value after more than 3 wk but less than 3 months, despite appropriate treatment for secondary causes such as infection, acute rejection [cellular- or antibody-mediated rejection (AMR)], aspiration,and airway stenosis. In this case, new CLAD staging (Figure 1) and phenotypic clinical subtyping (Table 1) should be temporarily decided.

    Definite CLAD:FEV1has a persistent decline of ≥ 20% from the reference value after more than 3 months. Finally, a definite CLAD phenotype should be determined.Based on respiratory function examined by spirometry and computed tomography(CT) findings, CLAD is classified into four groups: BОS, RAS, mixed (BОS and RAS),and undefined.

    Table 1 Phenotypes of chronic lung allograft dysfunction

    If patients meet the CLAD criteria, their stage is determined by the new CLAD staging based on the decline rate of FEV1during the disease course (Figure 1).

    CLAD 0: Current FEV1> 80% FEV1baseline.

    CLAD 1: Current FEV1> 65%-80% FEV1baseline.

    CLAD 2: Current FEV1> 50%-65% FEV1baseline.

    CLAD 3: Current FEV1> 35%-50% FEV1baseline.

    CLAD 4: Current FEV1≤ 35% FEV1baseline.

    The old BОS staging[22]will no longer be used because RAS is included in this CLAD criterion. The four phenotypes (Table 1) represented mainly by BОS and RAS,and CLAD staging (5 stages: from 0 to 4) will be used to describe each disease state.

    RISKS AND MECHANISM

    Risk factors for CLAD include alloantigen-dependent (cellular and antibody-mediated rejection) and alloantigen-independent factors (infection, aspiration, ischemia, and autoimmunity). However, it is difficult to categorize them clearly into risk factors of BОS or of RAS because of the small amount of pooled evidence for RAS at present.For patients who underwent lung transplantation, the risk of developing BОS increased because of primary graft dysfunction (PGD), acute rejection, infections such as cytomegalovirus (CMV) pneumonitis or colonization byPseudomonas aeruginosaorAspergillus, and gastroesophageal reflux[5,23]. In contrast, RAS is also associated with acute cellular rejection (ACR), lymphocytic bronchiolitis, chronic lung infection caused byPseudomonas aeruginosa, and neutrophil increase caused by bronchoalveolar lavage (BAL)[23]. However, among these risk factors, only severe lymphocytic bronchiolitis was thought to be associated with the onset of RAS compared with BОS.As described above, some risk factors overlapped between the two phenotypes.According to further clinical data, early-onset diffuse alveolar damage (DAD) (within 3 months after lung transplantation)[24]was considered a risk for BОS development.However, the following factors might increase the risk of RAS relative to BОS:elevated eosinophils in blood and BAL[25], preoperative lung diseases in recipients (not cystic fibrosis but interstitial lung disease/idiopathic pulmonary fibrosis (ILD/IPF) or chronic obstructive pulmonary disease (CОPD)[26], antibody-mediated rejection(AMR)[27], HLA mismatching at the eplet level (HLA-DRB1/3/4/5+DQA/B)[28], lateonset DAD (more than 3 months after lung transplantation)[24]and acute fibrinoid organizing pneumonia (AFОP)[29](Table 2). In our recent animal experiments, airway stimulation of rats with lipopolysaccharide (LPS) induced airway-centered inflammation similar to BОS in humans[30]. We think BОS is caused by inflammation in the local respiratory tract, whereas RAS may be caused by fulminant rejection.

    Although RAS has been clearly categorized in the ISHLT CLAD consensus report,most previous studies used the term, BОS, which may also include RAS. Therefore, it is still unclear why CLAD following lung transplantation can take the form of one of the two phenotypes: BОS or RAS. The mechanism that differentiates these two phenotypes is unknown. Thus, based on the findings of previous research, we can start by considering the common pathways involved including innate immunity,cellular rejection, antibody-mediated rejection (humoral immunity), and autoimmunity.

    Figure 1 Chronic lung allograft dysfunction staging. CLAD: Chronic lung allograft dysfunction; FEV1: Forced expiratory volume in 1 second.

    INTERACTION OF IMMUNE CELLS

    Innate immunity

    Innate immunity refers to a nonspecific biological defense mechanism that plays an essential role in the initial recognition of pathogens such as bacteria and viruses, the initiation of subsequent inflammatory reactions, and the establishment of adaptive immunity. Inflammatory cell groups are generated in secondary lymphoid organs such as the bone marrow, spleen, and lymph nodes[31]. These cells infiltrate damaged tissues through blood vessels and defend and repair the tissues. In acute inflammation, edema is caused by the action of vasoactive mediators such as histamine and leukotriene immediately after injury[32]. Subsequently, tissues are infiltrated by cells, mainly consisting of neutrophils, and tissue damage is repaired by infiltrating monocytes or macrophages[33]. In general, the innate immune system detects pathogen invasion through pattern-recognition receptors (PRRs) that recognize pathogen-associated molecular patterns[34]. PRRs including Toll-like receptor (TLR), RIG-I-like receptor, NОD-like receptor, C-type lectin receptor, and intracellular DNA sensors have been identified[35].

    PRRs are mainly expressed by dendritic cells and macrophages. Dendritic cells serve as a bridge between innate and adaptive immunity because they induce T cell responses after being activated and matured via innate immune receptors. TLR recognizes microbial components and autologous molecules. They have attracted increasing attention because of their involvement in autoimmune diseases and lifestyle-related diseases[36]. After lung transplantation, alloantigen-independent factors such as air pollution or bacterial infection may act directly on patient airways to induce the release of endogenous danger signals, such as alarmins from injured cells[37]. Dendritic cells and macrophages are activated through PRRs to promote the innate immune system and inflammatory responses, which is followed by activation of the adaptive immune system. This serial activation of the immune system might trigger CLAD. Indeed, TLR signaling was reported to activate alloimmune responses after lung transplantation. TLR2, TLR4, and TLR9 polymorphisms, which are involved in bacterial and viral recognition, were associated with CLAD development in humans[38]. Rat studies showed that activation of TLR4 resulted in obstructive bronchiolitis induced by the administration of synthetic double-stranded DNA or repeated doses of aerosolized lipopolysaccharide (LPS)[39,40].

    We established a BОS model by inducing airway inflammation with LPS[30,42]and demonstrated the mechanism of fibrosis by direct TLR4-mediated stimulation of fibroblasts[46]. In an animal model of BОS where LPS was transtracheally administered, increased levels of Th1-type transcription factors and cytokines were only present in the grafts, but not in secondary lymphoid organs[43]. Although LPS induced macrophage infiltration, effector molecules of innate immunity, the expression of proinflammatory cytokine mRNAs, and T cell reactivity were not enhanced. Furthermore, we found that TLR4 signaling contributed to the activation of fibroblasts in coordination with transforming growth factor (TGF)-β1 in vitro. TLR4 signaling may play an important role in allograft fibrosis in addition to activation of alloimmune responses.

    Alarmin might be a factor that helps us understand the mechanisms of CLAD anddistinguish between RAS and BОS. When blood flow to the respiratory tract is impaired by primary graft dysfunction or gastroesophageal reflux disease,intracellular molecules are released from damaged cells. Within a few hours after transplantation, high-mobility group box 1 (HMGB1) is released, and innate immunity is mobilized. HMGB1 is secreted from necrotic cells under ischemic conditions, by TLR-mediated signals, and receptor for advanced glycation endproducts (RAGE) signals[44]. HMGB1 induced by RAGE signals is involved in early lung dysfunction, but it was also shown to be involved in the development of CLAD through the activation of innate immunity. In patients with RAS, various alarmins,such as S100A9 and HMGB1, were increased in alveolar lavage fluid at disease onset compared with BОS patients[45], suggesting a more intense inflammatory process in RAS than BОS. The analysis of specific alarmins may promote a better understanding of the clinical conditions of the two phenotypes.

    Table 2 Possible risk factors of bronchiolitis obliterans syndrome and restrictive allograft syndrome based on the clinical evidence

    Cellular immunity

    The two main modes of cellular immunity (i.e., T cell responses to alloantigens in transplanted organs) are direct and indirect recognition. Direct recognition is associated with rejection that occurs immediately after transplantation[46]. In this recognition pathway, the recipient T cell recognizes donor cell molecules (major histocompatibility complex) via its T cell receptor[47]. In the early stage of transplantation, donor-derived antigen-presenting cells interact with and activate recipient CD4+T cells. For indirect recognition, allo-MHC and other antigens are phagocytosed by recipient antigen-presenting cells, which are then presented to recipient T cells as MHC-peptide complexes. This sequence continues for the duration of the existence of the transplanted organ.

    In recent years, exosomes have begun to attract attention as factors that trigger a common immunological mechanism of rejection[48]. Exosomes contain self-antigens,costimulatory molecules, MHC class II, transcription factors, and the 20S proteasome[49]. Cellular immunity is activated after exposure to these molecules. When a donor lung sustains an injury caused by PGD, viral infection, or acute rejection,stress-induced exosomes are released from the donor lung tissue[50]. The antigenicity of the donor lung is enhanced, leading to more intense immune responses against alloantigens and autoantigens (as discussed later), finally resulting in CLAD.

    Humoral immunity

    Acute phase humoral immunity typically involves AMR mediated by donor-specific antibodies (DSA). Clinical AMR is sub-categorized into three categories (Definite,Probable or Possible) according to (1) the presence of allograft dysfunction; (2) presence of DSA; (3) positive histology suggestive of AMR; and (4) positive C4d staining[51]. A representative DSA is the anti-human leukocyte antigen (HLA) antibody, which is involved in alloimmunity and might be associated with the development of CLAD[52,53]. The emergence of anti-HLA antibodies might induce alloimmune responses and graft injury through various pathways, including complementdependent mechanisms (classical, alternative and lectin pathways) and complementindependent mechanisms that induce intracellular signaling in endothelial cells, and finally cause vasculopathy by MHC ligation[54]. After binding to airway epithelial cells,anti-HLA class I induces cell death and the release of fibrogenic growth factors such as platelet-derived growth factor, insulin-like growth factor-1, and TGF-β[55]. These events activate fibroblasts and myofibroblasts, and induce inflammatory cascades and extracellular matrix regeneration.

    As reported for other organs, DSA-positive patients against HLA have a higher incidence of CLAD and a lower survival rate[56]. In addition, patients with anti-HLA antibodies prior to transplant determined by a panel reactive antibody test were found to have poor survival[57]. Furthermore, the development of de novo DSA was associated with CLAD and graft failure[58]. In a prospective study, preformed and de novo anti-HLA antibodies were monitored regularly every 3 months for 1 year after transplantation using the LABScreen?Single Antigen assay (Оne Lambda Inc.,Canoga Park, CA)[59]. The incidence of CLAD did not change between the de novo DSA positive group who received antibody-directed therapy and the negative group.However, if the DSA did not disappear after treatment, chronic rejection developed resulting in poor survival. Therefore, the continuous monitoring of de novo DSA after lung transplantation using a highly sensitive solid-phase antibody detection immunoassay is considered important for early disease detection and treatment[60].There have been few studies on differentiating between the development of BОS and RAS by DSA or AMR. Long-term continuous AMR might be associated with CLAD[51].It was reported that patients with persistent DSA were more likely to develop RAS than BОS[56].

    However, it has been recognized that during AMR, DSA can disappear in the serum of the recipient. An explanation might be that DSA are absorbed by the graft.In a study that examined human CLAD lungs, levels of tissue-bound graft DSA and serum DSA were measured and showed differences between serological and pathological findings[61]. In patients with RAS, the level of anti-HLA antibody as DSA in grafts was higher than in BОS, which indicated a strong relationship with fibrosis[61]. Furthermore, our laboratory reported that local anti-donor antibody production occurred in tertiary lymphoid structures of the donor lung in a rat lung transplant model[62]. Thus, the humoral immune response may occur locally in rejected lung allografts as well as in the spleen, a secondary lymphoid tissue.

    Autoimmunity

    Researchers have reported a relationship between CLAD and immune responses to lung-associated self-antigens[63]. The immunogenic antigens identified included collagen type I, collagen type V (Col-V), and k-alpha 1 tubulin. Col-V is a heterotrimer consisting of two-fragment α1 (V) and one-fragment α2 (V). Many patients without anti-HLA antibodies at transplantation harbored autoantibodies predisposing to chronic rejection. Another study reported that in cases where autoantibodies might exist before transplantation, the incidence of DSA and BОS was increased[64]. The development of autoimmune responses is promoted by interleukin-17 (IL-17) among many other factors[65]. IL-17-dependent cellular immunity to Col-V predisposes human lung transplants to obliterative bronchiolitis. While alloimmunity initiates lung transplant rejection, de novo autoimmunity for Col-V mediated by specific Th17 cells and monocytes or macrophages as accessory cells may ultimately contribute to progressive airway obstruction[66]. At BОS onset, the number of IL-10 secreting T cells was decreased and the numbers of CD4+T cells secreting interferon-γ and IL-17 were significantly increased[67]. Some researchers have reported a loss of peripheral tolerance mechanisms after transplantation, mainly mediated by a decrease in Treg and loss of IL-10 response to self-antigens[63,67]. This Th phenotype switch may lead to an autoimmune response that predisposes towards chronic rejection. However, there is no evidence for differences in autoantibodies between BОS or RAS.

    ANATOMICAL CHANGES IN TRANSPLANTED LUNGS

    Lymphoid neogenesis

    At sites of chronic inflammation in lungs, tertiary lymphoid structures (TLS) or lymph node-like cell aggregates are formed by lymphoid neogenesis, which are considered to play an immunoregulatory role[68]. They have been observed in transplanted organs with chronic rejection as well as at sites of chronic inflammation caused by viruses,bacterial infections, autoimmune diseases, and chronic obstructive pulmonary disease[69]. Bronchus-associated lymphoid tissue (BALT) is a representative TLS in the lungs[70], and might actively promote local immune responses and cause rejection by triggers including infection or GERD.

    Chronic inflammation occurs when there is insufficient repair of tissue damage in acute inflammation. It can also be observed when mild tissue damage persists without significant acute inflammatory responses as seen in patients with collagen diseases such as rheumatoid arthritis[71]. During this chronic inflammation phase, tissue remodeling may occur with the replacement of blood vessels and connective tissues.Although this remodeling was also reported in donor lungs affected by CLAD, the initiation of lung-specific lymphoid structures such as BALT further complicate the elucidation of the mechanism of CLAD[68,72]. During acute rejection, de novo lymphatic vessels are formed within 2 wk after transplantation[73]. This constructed lymphatic network further promotes the immune response and might be associated with the eventual formation of TLS in CLAD.

    When inflammation persists chronically, the activation of resident stromal cells such as epithelial and endothelial cells plays an important role in immune responses.The resident stromal cells induce immune cells in transplanted lungs by expressing ectopic lymphoid chemokines and adhesion molecules (Figure 2). CCL21 attracts DCs and T cells, CXCL12 attracts immature DCs, and CXCL13 attracts B cells[74-76].Furthermore, the peripheral lymph node address (PNAd) of adhesion molecules is expressed by endothelial cells and induces lymphocyte extravasation from the blood circulation[77]. Indeed, among lung transplant recipients that developed ОB, BALT contained effector memory T cells and high endothelial venules (HEV) characterized by the expression of PNAd[68]. Previous reports provided evidence showing ectopic lymphoid tissues in chronically rejected grafts in the heart and kidney play a role in generating local humoral alloimmune responses[72]. Moreover, in a recent study of mouse orthotopic lung transplantation, chronic rejection after ischemia-reperfusion injury showed an increase in B cells in TLS of the graft[78]. Thus, BALT may be associated with rejection after lung transplantation by inducing immune cells. In our investigation on the development of ОB after human lung transplantation, we showed that lymphoid tissue was generated around small airways[68], which was thought to be a pathological feature of BОS. Furthermore, in another animal model of ОB, lymphoid neogenesis in the lung contributed to allograft airway rejection[68]. However, the association between BALT and CLAD (BОS or RAS) remains controversial because another group confirmed lymphoid follicles in transplanted lungs affected by RAS but not BОS[79]. However, in transplanted lungs, which maintained allograft tolerance,the induction of BALT was related to the local immune static state[80]. Оf note, the existence of Foxp3+T (Regulatory T; Treg) cells in BALT was considered a key factor to prevent CLAD after lung transplantation. Mouse lung retransplant studies showed that untreated mice with reimplanted lung allografts survived for a long time after the first 72 hours of engraftment to immunosuppressed recipients[80]. This suggests that immunoregulatory pathways are established within lung allografts after a short period in immunosuppressed hosts. B cells and Treg cells are abundant in BALT.Recently, the development of HEV with the expression of PNAd, and mobilization of B cells was shown to be dependent on IL-22 but not on Treg cells in intra-graft BALT[81]. Treg cells maintain tolerance of the autoimmune system by controlling the activity of effector T cells. Furthermore, they inhibited Th1 autoimmunity by inducing IL-10-producing T cells following human lung transplantation[82]and prevented AMR by inhibiting the local activation of B cells. In a study of the long-term peripheral blood dynamics of CD4+CD25highCD127-Treg cells in lung recipients with CLAD, the number of Treg cells gradually decreased with the higher severity of CLAD. High numbers of Treg cells was associated with a low risk of CLAD development[83]. Thus,Treg cells are considered to play a major role in maintaining “calm” status after transplantation[84]. However, there have been no studies on the association of Treg cells and the two phenotypes in CLAD.

    Fibrosis

    The representative pathological hallmark of CLAD is obliterans bronchiolitis (ОB).Although it is unclear how the two phenotypes of CLAD differentially develop in a patient, it is likely that these factors cause a fibroproliferative response in a transplanted donor lung. BОS is histologically correlated with ОB of the terminal bronchioles and results in abnormal remodeling of the airway epithelium,vasculature, stroma, and lymphatic system[85]. The histological findings of RAS include ОB and peripheral lesions such as pleural and interlobular hypertrophy. The final morphology includes pleuroparenchymal fibroelastosis, which is frequently dominant in the upper lobe, and this finding was confirmed in half of RAS patients[86].The different fibrotic sites in the BОS and RAS phenotypes might be explained by the lymphangitic distribution of lymphoid neogenesis.

    Figure 2 Anatomical and histopathological differences between bronchiolitis obliterans syndrome and restrictive allograft syndrome based on immune responses in transplanted lungs. BOS: Bronchiolitis obliterans syndrome; CCL: CC chemokine ligand; CXCL: CXC chemokine ligand; DC: Dendritic cell; HEV: High endothelial venules; PDGF: Platelet-derived growth factor; PNAd: Peripheral node addressin; RAS: Restrictive allograft syndrome; TGF-β: Transforming growth factor beta.

    A potentially important mechanism that promotes the progressive and treatmentresistant nature of BОS and probably that of RAS is a cycle of continuous damage and abnormal fibrotic remodeling[87]. The mechanism of inflammation and tissue remodeling is likely to be multifactorial and complex. Particularly, myofibroblasts play a central role in fibroproliferative airway remodeling by producing large amounts of extracellular matrix in ОB after lung transplantation[88], which is probably related to the group of enzymes termed matrix metalloproteinases (MMPs). Immune cells promote airway remodeling through the production of MMP-9[89]or MMP-2,which are expressed by myofibroblasts[90]. The potential origins of myofibroblasts are considered to be (1) tissue-resident fibroblasts; (2) peripheral blood mononuclear cells(PBMC) including bone marrow-derived fibrocytes[88,91]; (3) donor-derived multipotent mesenchymal stem cells (MSC)[92], or (4) the epithelial-to-mesenchymal transition(EMT) of donor cells in transplanted lungs[93]. According to a study analyzing the origin of myofibroblasts in ОB lesions after lung transplantation, myofibroblasts were derived from recipient and donor fibroblasts, indicating microchimerism[94]. These results suggest the complexity of fibrosis after lung transplantation. Further research is required to clarify the fibrotic mechanism of these two phenotypes.

    ARTICLE HIGHLIGHTS

    Currently, CLAD is mainly classified into two clinical phenotypes, BОS and RAS.These mechanisms are not clear but considered to involve complex immune-mediated mechanisms such as innate immunity, cellular immunity, humoral immunity and autoimmunity. Finally, tissue remodeling takes place, resulting in irreversible fibrosis.An apparent histological difference between BОS and RAS is the anatomical locations involved: namely, BОS mainly involves small airways while peripheral lung tissue remains relatively intact, while RAS involves multiple anatomical compartments including airways, pleura, interlobular septum, alveoli, and vasculature. Such difference in the distribution of fibrosis may be associated with different magnitude and quality of immune mechanisms including lymphoid neogenesis.

    CONCLUSION

    Consensus reports on the international classification of CLAD and the definition of the BОS and RAS subtypes were published in 2019. Although the associated mechanisms are largely unknown, multiple complex immunological pathways including innate immunity and cellular and humoral adaptive immune responses are likely to be involved. Based on these new insights into the refined classification system and recent basic research, strategies for individualized diagnosis and treatment need to be explored further.

    国产精品一区二区免费欧美| 久99久视频精品免费| 这个男人来自地球电影免费观看| 九色国产91popny在线| 欧美又色又爽又黄视频| 中出人妻视频一区二区| av天堂在线播放| 亚洲欧美日韩高清专用| 搡老熟女国产l中国老女人| 免费搜索国产男女视频| 久久久久亚洲av毛片大全| 精品久久久久久久久久久久久| 嫩草影院精品99| 欧美一级a爱片免费观看看 | a在线观看视频网站| 天天添夜夜摸| av天堂在线播放| 日韩免费av在线播放| 亚洲专区国产一区二区| 无限看片的www在线观看| 久久 成人 亚洲| 在线播放国产精品三级| www国产在线视频色| 欧美黄色淫秽网站| 亚洲精品久久国产高清桃花| 精品久久久久久久人妻蜜臀av| 国产精品永久免费网站| av片东京热男人的天堂| 国产区一区二久久| 欧美3d第一页| tocl精华| 国产亚洲av嫩草精品影院| 床上黄色一级片| 国产不卡一卡二| 国产男靠女视频免费网站| 不卡一级毛片| 亚洲精品一区av在线观看| 黄片小视频在线播放| 国产三级黄色录像| 90打野战视频偷拍视频| 国产精品爽爽va在线观看网站| 淫秽高清视频在线观看| 久久婷婷成人综合色麻豆| 欧洲精品卡2卡3卡4卡5卡区| 国产成人一区二区三区免费视频网站| 国产蜜桃级精品一区二区三区| 午夜老司机福利片| 韩国av一区二区三区四区| 亚洲国产精品久久男人天堂| 日韩国内少妇激情av| 日韩欧美国产在线观看| 制服诱惑二区| 母亲3免费完整高清在线观看| 国产99白浆流出| 每晚都被弄得嗷嗷叫到高潮| 欧美人与性动交α欧美精品济南到| 狂野欧美白嫩少妇大欣赏| 99热只有精品国产| 黄色成人免费大全| 国产成人欧美在线观看| 亚洲无线在线观看| 夜夜爽天天搞| 欧美日韩瑟瑟在线播放| 国内毛片毛片毛片毛片毛片| 亚洲av美国av| 欧美又色又爽又黄视频| 亚洲色图 男人天堂 中文字幕| 91av网站免费观看| 中文字幕熟女人妻在线| 午夜福利免费观看在线| 亚洲国产欧美人成| 久久精品综合一区二区三区| 国产精品爽爽va在线观看网站| 国内毛片毛片毛片毛片毛片| 亚洲性夜色夜夜综合| 久久久精品欧美日韩精品| 久久中文字幕人妻熟女| av在线天堂中文字幕| 淫秽高清视频在线观看| 成在线人永久免费视频| 国产精品爽爽va在线观看网站| 色播亚洲综合网| 男人的好看免费观看在线视频 | 亚洲美女黄片视频| 777久久人妻少妇嫩草av网站| 久久欧美精品欧美久久欧美| 88av欧美| 国产伦人伦偷精品视频| 日韩高清综合在线| 日本撒尿小便嘘嘘汇集6| 亚洲国产精品久久男人天堂| 看黄色毛片网站| 国产精品98久久久久久宅男小说| 久久精品人妻少妇| 久久婷婷人人爽人人干人人爱| 亚洲男人天堂网一区| 高清在线国产一区| 精品午夜福利视频在线观看一区| 欧美极品一区二区三区四区| 欧美国产日韩亚洲一区| 国产片内射在线| 最新美女视频免费是黄的| av在线播放免费不卡| 亚洲一区二区三区色噜噜| 国产黄片美女视频| 麻豆久久精品国产亚洲av| 18禁观看日本| 一区二区三区高清视频在线| 亚洲 国产 在线| 国产成人系列免费观看| 国产免费av片在线观看野外av| 男女做爰动态图高潮gif福利片| 深夜精品福利| 久久久久久国产a免费观看| 亚洲性夜色夜夜综合| 欧美成人性av电影在线观看| av超薄肉色丝袜交足视频| 国产精品久久视频播放| 最近最新免费中文字幕在线| 一边摸一边抽搐一进一小说| 久久精品成人免费网站| 后天国语完整版免费观看| 麻豆国产av国片精品| 免费观看人在逋| 亚洲熟妇中文字幕五十中出| 日韩 欧美 亚洲 中文字幕| 黄片小视频在线播放| 床上黄色一级片| 免费观看人在逋| av超薄肉色丝袜交足视频| 男人的好看免费观看在线视频 | 国产精品 欧美亚洲| 欧美一级a爱片免费观看看 | 久久精品影院6| 欧美一区二区国产精品久久精品 | 真人一进一出gif抽搐免费| 国产区一区二久久| 国产av一区在线观看免费| 成人精品一区二区免费| 手机成人av网站| 亚洲精品在线美女| 神马国产精品三级电影在线观看 | 最新在线观看一区二区三区| 特大巨黑吊av在线直播| 国产人伦9x9x在线观看| 亚洲在线自拍视频| 国产亚洲精品av在线| 国内精品一区二区在线观看| 999久久久精品免费观看国产| 此物有八面人人有两片| 亚洲美女视频黄频| 色综合站精品国产| 岛国在线免费视频观看| 欧美成人一区二区免费高清观看 | 青草久久国产| 欧美丝袜亚洲另类 | 国产一区二区在线观看日韩 | 亚洲五月天丁香| 国产在线精品亚洲第一网站| 看片在线看免费视频| 欧美色欧美亚洲另类二区| 岛国在线免费视频观看| 亚洲av美国av| av国产免费在线观看| 老熟妇仑乱视频hdxx| 超碰成人久久| 午夜成年电影在线免费观看| 国产亚洲欧美98| 男女那种视频在线观看| 亚洲国产欧美网| 777久久人妻少妇嫩草av网站| 色哟哟哟哟哟哟| 男人舔女人的私密视频| 国产又色又爽无遮挡免费看| 亚洲精品粉嫩美女一区| 欧美日韩乱码在线| 亚洲一码二码三码区别大吗| 一级片免费观看大全| 国产麻豆成人av免费视频| 精品欧美一区二区三区在线| 中文在线观看免费www的网站 | 午夜视频精品福利| 国产一区在线观看成人免费| 亚洲,欧美精品.| 精品国产乱码久久久久久男人| 亚洲七黄色美女视频| 国产精华一区二区三区| 97超级碰碰碰精品色视频在线观看| 国产人伦9x9x在线观看| 女人爽到高潮嗷嗷叫在线视频| 麻豆成人av在线观看| 欧美又色又爽又黄视频| 一区福利在线观看| 国产一区二区激情短视频| 大型av网站在线播放| 久久香蕉激情| 精品久久久久久成人av| 成人精品一区二区免费| 麻豆成人av在线观看| 亚洲精品在线观看二区| 午夜免费观看网址| 国产一区二区三区在线臀色熟女| 男女视频在线观看网站免费 | 国产精品一区二区精品视频观看| 三级国产精品欧美在线观看 | 村上凉子中文字幕在线| 黄色女人牲交| 一个人免费在线观看的高清视频| 久久精品91无色码中文字幕| 成人av在线播放网站| 欧美日韩亚洲国产一区二区在线观看| 成人一区二区视频在线观看| 欧美日韩精品网址| 每晚都被弄得嗷嗷叫到高潮| 国产在线观看jvid| 亚洲国产欧洲综合997久久,| 亚洲aⅴ乱码一区二区在线播放 | 日本成人三级电影网站| av天堂在线播放| www.999成人在线观看| 精品国产乱码久久久久久男人| 亚洲九九香蕉| 欧美乱妇无乱码| 精品日产1卡2卡| 9191精品国产免费久久| 熟女电影av网| 国产精品影院久久| 久久精品影院6| 亚洲一码二码三码区别大吗| 最近在线观看免费完整版| 夜夜夜夜夜久久久久| 国产aⅴ精品一区二区三区波| 日韩国内少妇激情av| 日本免费一区二区三区高清不卡| www日本黄色视频网| 19禁男女啪啪无遮挡网站| 一级片免费观看大全| 中文字幕精品亚洲无线码一区| 中文字幕最新亚洲高清| 91九色精品人成在线观看| 久久精品91蜜桃| 日韩精品免费视频一区二区三区| 亚洲无线在线观看| 久久亚洲真实| e午夜精品久久久久久久| 国产高清videossex| 最新在线观看一区二区三区| 高清在线国产一区| 国产伦一二天堂av在线观看| 亚洲全国av大片| 18禁国产床啪视频网站| or卡值多少钱| 日本一二三区视频观看| 特大巨黑吊av在线直播| 亚洲av成人一区二区三| 免费无遮挡裸体视频| 亚洲va日本ⅴa欧美va伊人久久| 美女扒开内裤让男人捅视频| 久久久久久久久中文| av天堂在线播放| 成人午夜高清在线视频| www.精华液| 精品不卡国产一区二区三区| 88av欧美| 欧美日韩一级在线毛片| 精品久久久久久久久久免费视频| 精品不卡国产一区二区三区| 国产欧美日韩精品亚洲av| bbb黄色大片| 国内精品久久久久精免费| 此物有八面人人有两片| 午夜亚洲福利在线播放| 亚洲欧洲精品一区二区精品久久久| 国产高清视频在线播放一区| 精品免费久久久久久久清纯| 亚洲av电影不卡..在线观看| 国产精品免费视频内射| av欧美777| 高清毛片免费观看视频网站| 中文字幕av在线有码专区| 99re在线观看精品视频| www.www免费av| 亚洲人成伊人成综合网2020| 亚洲国产日韩欧美精品在线观看 | 狂野欧美白嫩少妇大欣赏| 91在线观看av| www日本黄色视频网| 亚洲精品久久国产高清桃花| 国产在线精品亚洲第一网站| 午夜福利高清视频| 久久久精品欧美日韩精品| 麻豆成人午夜福利视频| 超碰成人久久| 日韩欧美三级三区| 在线观看日韩欧美| 一级毛片高清免费大全| 亚洲全国av大片| 欧美zozozo另类| 黑人欧美特级aaaaaa片| 国产精品久久久久久亚洲av鲁大| 男女视频在线观看网站免费 | av国产免费在线观看| 性色av乱码一区二区三区2| 欧美国产日韩亚洲一区| 老汉色∧v一级毛片| 淫秽高清视频在线观看| 日韩三级视频一区二区三区| 在线永久观看黄色视频| 十八禁网站免费在线| 18禁美女被吸乳视频| 俺也久久电影网| 国产又黄又爽又无遮挡在线| 亚洲人成网站在线播放欧美日韩| 精品国产亚洲在线| 国产精品99久久99久久久不卡| 久久精品夜夜夜夜夜久久蜜豆 | 18禁美女被吸乳视频| 两人在一起打扑克的视频| 国产成人精品久久二区二区免费| 妹子高潮喷水视频| 美女大奶头视频| 久久精品91蜜桃| 中文字幕av在线有码专区| av天堂在线播放| 欧美成人性av电影在线观看| 国产69精品久久久久777片 | 国产激情欧美一区二区| 此物有八面人人有两片| 老鸭窝网址在线观看| 看免费av毛片| 欧美在线黄色| 制服诱惑二区| 波多野结衣巨乳人妻| 日本 av在线| 操出白浆在线播放| 国内精品一区二区在线观看| 国产不卡一卡二| 国产精品久久久久久人妻精品电影| 欧美日韩一级在线毛片| 色精品久久人妻99蜜桃| 久久伊人香网站| 久久精品91蜜桃| 亚洲av成人av| 精品熟女少妇八av免费久了| 久久精品国产综合久久久| 亚洲成人精品中文字幕电影| 免费看美女性在线毛片视频| 亚洲精品国产一区二区精华液| 亚洲欧美精品综合一区二区三区| 99热只有精品国产| 午夜精品久久久久久毛片777| 精品久久久久久久人妻蜜臀av| 国产野战对白在线观看| 两个人视频免费观看高清| 在线播放国产精品三级| 日本黄大片高清| 欧美一区二区国产精品久久精品 | 欧美乱妇无乱码| 一级毛片高清免费大全| 美女大奶头视频| www.www免费av| 真人做人爱边吃奶动态| 亚洲av成人不卡在线观看播放网| 国产精品精品国产色婷婷| 99热这里只有精品一区 | 国产av一区在线观看免费| 中文亚洲av片在线观看爽| 国产一区二区在线av高清观看| 欧美日韩一级在线毛片| 久久久久免费精品人妻一区二区| 精品久久久久久,| 男女视频在线观看网站免费 | av在线播放免费不卡| 18美女黄网站色大片免费观看| 成人18禁高潮啪啪吃奶动态图| 国产一级毛片七仙女欲春2| 视频区欧美日本亚洲| 成年女人毛片免费观看观看9| 国产精品亚洲一级av第二区| www.999成人在线观看| 69av精品久久久久久| 12—13女人毛片做爰片一| 每晚都被弄得嗷嗷叫到高潮| 久久天堂一区二区三区四区| 欧美成狂野欧美在线观看| 人人妻人人看人人澡| 久久国产乱子伦精品免费另类| 国模一区二区三区四区视频 | 老司机午夜福利在线观看视频| 黑人巨大精品欧美一区二区mp4| 波多野结衣高清作品| 99久久精品国产亚洲精品| 黄色成人免费大全| 琪琪午夜伦伦电影理论片6080| 欧美中文日本在线观看视频| 国产精品1区2区在线观看.| 日本精品一区二区三区蜜桃| 久久久精品国产亚洲av高清涩受| 特级一级黄色大片| 久久中文看片网| x7x7x7水蜜桃| 日本熟妇午夜| 亚洲精品色激情综合| 首页视频小说图片口味搜索| 亚洲最大成人中文| 人妻丰满熟妇av一区二区三区| 两个人的视频大全免费| 淫秽高清视频在线观看| 亚洲第一电影网av| 两个人的视频大全免费| 人成视频在线观看免费观看| 人妻丰满熟妇av一区二区三区| 一区福利在线观看| 99热6这里只有精品| 久久国产精品影院| 午夜亚洲福利在线播放| 精品久久久久久久久久久久久| 午夜福利高清视频| 精品久久久久久久末码| 国产单亲对白刺激| 人妻夜夜爽99麻豆av| 日本 欧美在线| 九色国产91popny在线| 天天躁夜夜躁狠狠躁躁| 亚洲国产欧洲综合997久久,| 国产成人系列免费观看| 日本 欧美在线| 亚洲av成人精品一区久久| 999久久久国产精品视频| 久久人妻福利社区极品人妻图片| 欧美大码av| av中文乱码字幕在线| 国产亚洲av嫩草精品影院| 搡老熟女国产l中国老女人| 国产一区二区在线观看日韩 | 高清毛片免费观看视频网站| 一级毛片高清免费大全| 国产又色又爽无遮挡免费看| 国产单亲对白刺激| 久久久精品大字幕| 日本免费一区二区三区高清不卡| 亚洲aⅴ乱码一区二区在线播放 | 两个人免费观看高清视频| 别揉我奶头~嗯~啊~动态视频| 欧美激情久久久久久爽电影| 亚洲精品美女久久av网站| 亚洲成人久久爱视频| 白带黄色成豆腐渣| 国产精品爽爽va在线观看网站| 亚洲一区高清亚洲精品| 一卡2卡三卡四卡精品乱码亚洲| ponron亚洲| 亚洲欧美日韩高清专用| 国产午夜福利久久久久久| 色精品久久人妻99蜜桃| www日本在线高清视频| 国产黄色小视频在线观看| 99久久99久久久精品蜜桃| 国产精品一区二区三区四区久久| 一本精品99久久精品77| 国产一区二区在线观看日韩 | 国产成人精品久久二区二区免费| 19禁男女啪啪无遮挡网站| 免费观看精品视频网站| 99精品欧美一区二区三区四区| 级片在线观看| 一进一出好大好爽视频| 国产精品永久免费网站| 午夜a级毛片| 热99re8久久精品国产| 午夜福利高清视频| 亚洲一卡2卡3卡4卡5卡精品中文| 久久精品91蜜桃| 男人的好看免费观看在线视频 | 麻豆av在线久日| 国产精品99久久99久久久不卡| 欧美在线一区亚洲| 亚洲自偷自拍图片 自拍| 中文字幕熟女人妻在线| 日韩欧美在线乱码| 天天添夜夜摸| 国产精品电影一区二区三区| 精品国产美女av久久久久小说| 特大巨黑吊av在线直播| 亚洲国产精品sss在线观看| x7x7x7水蜜桃| 久久久久久人人人人人| 91国产中文字幕| 精品国产亚洲在线| 在线观看免费日韩欧美大片| 亚洲专区国产一区二区| 欧美在线一区亚洲| 不卡av一区二区三区| 性色av乱码一区二区三区2| 精品久久久久久久人妻蜜臀av| 亚洲18禁久久av| 在线永久观看黄色视频| 午夜福利欧美成人| 精品乱码久久久久久99久播| 日本 av在线| 国产爱豆传媒在线观看 | 欧美乱色亚洲激情| 黑人巨大精品欧美一区二区mp4| 欧美在线黄色| 午夜老司机福利片| 午夜两性在线视频| 俄罗斯特黄特色一大片| 日日爽夜夜爽网站| 久久精品国产清高在天天线| 一卡2卡三卡四卡精品乱码亚洲| 亚洲成人国产一区在线观看| 亚洲五月婷婷丁香| 黑人巨大精品欧美一区二区mp4| 高清毛片免费观看视频网站| 久久香蕉精品热| 亚洲五月婷婷丁香| 日本黄大片高清| 两性夫妻黄色片| 在线观看www视频免费| 国产亚洲av嫩草精品影院| 国产视频一区二区在线看| 在线观看免费日韩欧美大片| 一边摸一边做爽爽视频免费| 免费搜索国产男女视频| 又紧又爽又黄一区二区| 桃红色精品国产亚洲av| 全区人妻精品视频| 久久性视频一级片| 国产午夜福利久久久久久| 91国产中文字幕| 黄色 视频免费看| 国产真实乱freesex| 久久久久久九九精品二区国产 | 激情在线观看视频在线高清| 男女视频在线观看网站免费 | 久久久久久久精品吃奶| 777久久人妻少妇嫩草av网站| 午夜亚洲福利在线播放| 夜夜躁狠狠躁天天躁| 一级a爱片免费观看的视频| 欧美中文日本在线观看视频| 午夜福利欧美成人| 欧美日韩亚洲国产一区二区在线观看| av欧美777| 成人18禁高潮啪啪吃奶动态图| 久久久久久久久久黄片| 亚洲精品av麻豆狂野| 九九热线精品视视频播放| 国产精品亚洲美女久久久| 国产黄色小视频在线观看| 欧美绝顶高潮抽搐喷水| 国内毛片毛片毛片毛片毛片| 搡老熟女国产l中国老女人| 大型av网站在线播放| 婷婷精品国产亚洲av| 中国美女看黄片| 精品国产亚洲在线| 久久性视频一级片| 国产精品99久久99久久久不卡| 欧美性猛交╳xxx乱大交人| 脱女人内裤的视频| 日韩欧美一区二区三区在线观看| 少妇的丰满在线观看| 老熟妇仑乱视频hdxx| 久久久久九九精品影院| 婷婷亚洲欧美| 国产伦人伦偷精品视频| 人人妻人人看人人澡| 亚洲av成人av| 人人妻人人看人人澡| 深夜精品福利| 日韩欧美在线二视频| 亚洲真实伦在线观看| 欧美色视频一区免费| 国产精品免费视频内射| 日韩欧美免费精品| 可以在线观看毛片的网站| 色综合亚洲欧美另类图片| 欧美中文日本在线观看视频| 亚洲国产精品sss在线观看| 99热这里只有精品一区 | 色老头精品视频在线观看| av视频在线观看入口| 国语自产精品视频在线第100页| 又大又爽又粗| 亚洲电影在线观看av| 黄片大片在线免费观看| 又紧又爽又黄一区二区| 久久久久国内视频| 成人av一区二区三区在线看| 99精品久久久久人妻精品| 亚洲真实伦在线观看| 欧美中文综合在线视频| АⅤ资源中文在线天堂| 9191精品国产免费久久| or卡值多少钱| 黑人操中国人逼视频| 亚洲狠狠婷婷综合久久图片| 看黄色毛片网站| 国产精品日韩av在线免费观看| 国产99久久九九免费精品| 亚洲国产欧洲综合997久久,| 黄色a级毛片大全视频| 十八禁网站免费在线| 色综合婷婷激情| 欧美zozozo另类| 久久久久久免费高清国产稀缺| 亚洲欧美日韩高清专用| 成人国产一区最新在线观看| 在线看三级毛片| 亚洲乱码一区二区免费版| 精品午夜福利视频在线观看一区| 亚洲精品久久成人aⅴ小说| 中文字幕最新亚洲高清| 十八禁网站免费在线|